Chronic Disease Wellness Programs And Health Care Case Study
What is the impact of chronic disease wellness programs on health care costs?
There is a high impact on health care cost due to chronic diseases. This is mainly due to the lowering of the mortality rate of chronic diseases. In the past there were less people living with these types of diseases or surviving them. There is also an increase in the diagnosis of these types of diseases. With the newer technologies they are able to diagnose more patients properly with these diseases as well as diagnose them early enough to treat them or cure them if possible. Here is some information I found concerning a couple of these chronic diseases:
Diabetes
Whereas the mortality of the previous two diseases is declining, the mortality of diabetes in
the general population is increasing by 1.2% annually. Coupled with an exponential growth in the diabetic population (11 million in 2000, 23.6 million in 2009), and a predicted 52.9% increase in incidence rate between 2003 and 2023, the human and economic burden of diabetes in the future is certain to be overwhelming.
Currently 10% of health care dollars are spent on overall direct costs related to diabetes, amounting to $92 billion a year (1.5 times the amount spent on stroke or heart disease). The Centers for Disease Control and Prevention predicts that spending on diabetes care will reach $192 billion in 2020.
Medicare reported spending only $1.4 billion ($7,383 per discharge) on diabetes in 2007, but this number is limited to in-patient services, which excludes most diabetic care, such as insulin therapy.
Chronic Lung Disease
The Centers for Disease Control and Prevention lists fourth leading cause of death in the adult population as chronic lower respiratory disease, which includes bronchitis, emphysema, COPD, and asthma. The mortality of chronic lung disease is predicted to decrease at a rate of 1.5% a year until 2030, and yet the cost of treating it is predicted to more than double from $176.8 billion in 2006 to $389.2 billion in 2011 and to reach $832.9 billion in 2021. The reason for this skyrocketing increase is a 31.1% increase in the number of diagnoses predicted by the Milken Institute.
Medicare spent over $8 billion on respiratory disease, excluding pneumonia, in 2006, a figure that is bound to increase tremendously in the next decade.
Reference:
http://healthcarecostmonitor.thehastingscenter.org/kimberlyswartz/projected-costs-of-chronic-diseases/#ixzz1wUbsy4ZJ
There is a high impact on health care cost due to chronic diseases. This is mainly due to the lowering of the mortality rate of chronic diseases. In the past there were less people living with these types of diseases or surviving them. There is also an increase in the diagnosis of these types of diseases. With the newer technologies they are able to diagnose more patients properly with these diseases as well as diagnose them early enough to treat them or cure them if possible. Here is some information I found concerning a couple of these chronic diseases:
Diabetes
Whereas the mortality of the previous two diseases is declining, the mortality of diabetes in
the general population is increasing by 1.2% annually. Coupled with an exponential growth in the diabetic population (11 million in 2000, 23.6 million in 2009), and a predicted 52.9% increase in incidence rate between 2003 and 2023, the human and economic burden of diabetes in the future is certain to be overwhelming.
Currently 10% of health care dollars are spent on overall direct costs related to diabetes, amounting to $92 billion a year (1.5 times the amount spent on stroke or heart disease). The Centers for Disease Control and Prevention predicts that spending on diabetes care will reach $192 billion in 2020.
Medicare reported spending only $1.4 billion ($7,383 per discharge) on diabetes in 2007, but this number is limited to in-patient services, which excludes most diabetic care, such as insulin therapy.
Chronic Lung Disease
The Centers for Disease Control and Prevention lists fourth leading cause of death in the adult population as chronic lower respiratory disease, which includes bronchitis, emphysema, COPD, and asthma. The mortality of chronic lung disease is predicted to decrease at a rate of 1.5% a year until 2030, and yet the cost of treating it is predicted to more than double from $176.8 billion in 2006 to $389.2 billion in 2011 and to reach $832.9 billion in 2021. The reason for this skyrocketing increase is a 31.1% increase in the number of diagnoses predicted by the Milken Institute.
Medicare spent over $8 billion on respiratory disease, excluding pneumonia, in 2006, a figure that is bound to increase tremendously in the next decade.
Reference:
http://healthcarecostmonitor.thehastingscenter.org/kimberlyswartz/projected-costs-of-chronic-diseases/#ixzz1wUbsy4ZJ